<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
11014-0687-2
</NDCCode>
<PackageDescription>
1 BOTTLE, UNIT-DOSE in 1 TUBE (11014-0687-2) / 1 POWDER in 1 BOTTLE, UNIT-DOSE
</PackageDescription>
<NDC11Code>
11014-0687-02
</NDC11Code>
<ProductNDC>
11014-0687
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Glucagon
</NonProprietaryName>
<DosageFormName>
POWDER
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20240131
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Catalent Pharma Solutions LLC
</LabelerName>
<SubstanceName>
GLUCAGON
</SubstanceName>
<StrengthNumber>
3
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
31-JAN-24
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>